Now Reading
Parkinson's Disease Foundation (PDF) Executive Director to Ring the NASDAQ StockMarket Closing Bell
Parkinson's Disease Foundation (PDF) Executive Director to Ring the NASDAQ StockMarket Closing Bell
Published 04-02-08
Submitted by NASDAQ OMX Group, Inc., The
ADVISORY, April 2, 2008 (PRIME NEWSWIRE) --
Who:
Robin Elliott, Executive Director of the Parkinson's Disease Foundation
(PDF) will preside over the Closing Bell.
Where:
NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio
When:
Wednesday, April 2 at 4:00 p.m. EST
Contacts:
Christiana M. Evers
Director of Communications
Parkinson's Disease Foundation (PDF)
Ph: (212) 923-4700/ (800) 457-6676
cevers@pdf.org
NASDAQ MarketSite:
Jolene Libretto
646.441.5220
Jolene.Libretto@NASDAQOMX.com
Feed Information:
The Closing Bell is available from 3:50 p.m. to 4:05 p.m. on uplink
IA-6 C-band/transponder 17. The downlink frequency is 4040 Vertical; Audio 6.2-6.8. The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Jolene Libretto at (646) 441-5220.
Radio Feed:
An audio transmission of the Closing Bell is also available from 3:50 p.m. to 4:05 p.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can be found on Waterfront fiber
1623 as well.
Webcast:
A live Webcast of the NASDAQ Closing Bell will be available at:
http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos:
To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.
About the Parkinson's Disease Foundation (PDF):
The Parkinson's Disease Foundation (PDF) is a leading national presence in Parkinson's disease research, education and public advocacy. We are working for the nearly one million people in the U.S. living with Parkinson's by funding promising scientific research and supporting people with Parkinson's, their families and caregivers through education programs and support services. Since our founding in 1957, PDF has funded over $70 million worth of scientific research in Parkinson's disease, supporting the work of leading scientists throughout the world.
